CLOLAR DIN 02330407
Health Canada record
| Active ingredient(s) | CLOFARABINE 1 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BB06 CLOFARABINE |
| Original market date | 10-Feb-2010 |
| Current status date | 08-Apr-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
sanofi-aventis Canada Inc. — licence 101470, currently licensed, last inspection rating C (2026-02-17).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14324 | 2013-04-30 | New Drug Submission (NDS) | Manufacturer name change |
| 10380 | 2009-07-16 | New Drug Submission (NDS) |
International API supply for CLOFARABINE
11 active FDA Drug Master Files.
Request a quote for CLOLAR